Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.
Delyon J, Porcher R, Battistella M, Meyer N, Adamski H, Bertucci F, Guillot B, Jouary T, Leccia MT, Dalac S, Mortier L, Ghrieb Z, Da Meda L, Vicaut E, Pedeutour F, Mourah S, Lebbe C. Delyon J, et al. Among authors: adamski h. J Invest Dermatol. 2021 Apr;141(4):761-769.e2. doi: 10.1016/j.jid.2020.06.039. Epub 2020 Sep 18. J Invest Dermatol. 2021. PMID: 32956651 Free article. Clinical Trial.
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.
Martin L, Piette F, Blanc P, Mortier L, Avril MF, Delaunay MM, Dréno B, Granel F, Mantoux F, Aubin F, Sassolas B, Adamski H, Dalac S, Pauwels C, Dompmartin A, Lok C, Estève E, Guillot B; French Group for Cutaneous Oncology. Martin L, et al. Among authors: adamski h. Br J Dermatol. 2005 Nov;153(5):932-6. doi: 10.1111/j.1365-2133.2005.06823.x. Br J Dermatol. 2005. PMID: 16225602
Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study.
Aubin F, Porcher R, Jeanmougin M, Léonard F, Bedane C, Moreau A, Schmutz JL, Marguery MC, Adamski H, Viguier M; Société Française de Photodermatologie. Aubin F, et al. Among authors: adamski h. J Am Acad Dermatol. 2014 Nov;71(5):948-953.e1. doi: 10.1016/j.jaad.2014.07.023. Epub 2014 Aug 16. J Am Acad Dermatol. 2014. PMID: 25135650 Clinical Trial.
Do the Side Effects of BRAF Inhibitors Mimic RASopathies?
Sfecci A, Dupuy A, Dinulescu M, Droitcourt C, Adamski H, Hadj-Rabia S, Odent S, Galibert MD, Boussemart L. Sfecci A, et al. Among authors: adamski h. J Invest Dermatol. 2017 Apr;137(4):805-809. doi: 10.1016/j.jid.2016.12.012. J Invest Dermatol. 2017. PMID: 28340684 Free article. Review.
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
Pacot L, Sabbagh A, Sohier P, Hadjadj D, Ye M, Boland-Auge A, Bacq-Daian D, Laurendeau I, Briand-Suleau A, Deleuze JF, Margueron R, Vidaud M, Ferkal S, Parfait B, Vidaud D; NF-France Network; Pasmant E, Wolkenstein P. Pacot L, et al. Br J Dermatol. 2024 Jan 23;190(2):226-243. doi: 10.1093/bjd/ljad390. Br J Dermatol. 2024. PMID: 37831592
Physicians involved in the care of patients with high risk of skin cancer should be trained regarding sun protection measures: evidence from a cross sectional study.
Thomas M, Rioual E, Adamski H, Roguedas AM, Misery L, Michel M, Chastel F, Schmutz JL, Aubin F, Marguery MC, Meyer N. Thomas M, et al. Among authors: adamski h. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):19-23. doi: 10.1111/j.1468-3083.2010.03673.x. J Eur Acad Dermatol Venereol. 2011. PMID: 20456547
102 results